Literature DB >> 24510185

Surrogate markers of overall survival in metastatic colorectal cancer: an evolving challenge still more complex with repeat surgery.

René Adam1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24510185      PMCID： PMC5101349          DOI： 10.1245/s10434-014-3513-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  6 in total

1.  Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?

Authors:  Rene Adam; Prashant Bhangui; Graeme Poston; Darius Mirza; Gennaro Nuzzo; Eduardo Barroso; Jan Ijzermans; Catherine Hubert; Theo Ruers; Lorenzo Capussotti; Jean-Francois Ouellet; Christophe Laurent; Esteban Cugat; Pierre Emmanuel Colombo; Miroslav Milicevic
Journal:  Ann Surg       Date:  2010-11       Impact factor: 12.969

2.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Murielle Mauer; Erik Tanis; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet Oncol       Date:  2013-10-11       Impact factor: 41.316

3.  Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Authors:  Daniel J Sargent; Harry S Wieand; Daniel G Haller; Richard Gray; Jacqueline K Benedetti; Marc Buyse; Roberto Labianca; Jean Francois Seitz; Christopher J O'Callaghan; Guido Francini; Axel Grothey; Michael O'Connell; Paul J Catalano; Charles D Blanke; David Kerr; Erin Green; Norman Wolmark; Thierry Andre; Richard M Goldberg; Aimery De Gramont
Journal:  J Clin Oncol       Date:  2005-10-31       Impact factor: 44.544

Review 4.  Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.

Authors:  Koji Oba; Xavier Paoletti; Steven Alberts; Yung-Jue Bang; Jacqueline Benedetti; Harry Bleiberg; Paul Catalano; Florian Lordick; Stefan Michiels; Satoshi Morita; Yasuo Ohashi; Jean-Pierre Pignon; Philippe Rougier; Mitsuru Sasako; Junichi Sakamoto; Daniel Sargent; Kohei Shitara; Eric Van Cutsem; Marc Buyse; Tomasz Burzykowski
Journal:  J Natl Cancer Inst       Date:  2013-10-09       Impact factor: 13.506

5.  Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.

Authors:  Xavier Paoletti; Koji Oba; Yung-Jue Bang; Harry Bleiberg; Narikazu Boku; Olivier Bouché; Paul Catalano; Nozomu Fuse; Stefan Michiels; Markus Moehler; Satoshi Morita; Yasuo Ohashi; Atsushi Ohtsu; Arnaud Roth; Philippe Rougier; Junichi Sakamoto; Daniel Sargent; Mitsuru Sasako; Kohei Shitara; Peter Thuss-Patience; Eric Van Cutsem; Tomasz Burzykowski; Marc Buyse
Journal:  J Natl Cancer Inst       Date:  2013-10-09       Impact factor: 13.506

6.  Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.

Authors:  Susan Halabi; Brian Rini; Bernard Escudier; Walter M Stadler; Eric J Small
Journal:  Cancer       Date:  2013-10-08       Impact factor: 6.860
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.